ArticleJournal for immunotherapy of cancer2024

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events.

Limor Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.